The latest quarterly retained earnings is −$75.55 Million with a QoQ Growth of -4.66%. Retained earnings represent the cumulative net income that has been kept by the company rather than distributed to shareholders as dividends. It's a key component of shareholders' equity.
Q2 FY2026 (2026-06-30).
Reported quarterly retained earnings; no daily interpolation. Q2 FY2026 (2026-06-30): $-75.55M.
−$75.55M
−$75.55 Million
Q2 FY2026 · 2026-06-30
-4.66%
vs. −$72.18M prior quarter
22
Quarters of data available
| Period | Retained Earnings | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | −$75.55M | -4.66% | -25.16% |
| Q1 FY2026Period end 2026-03-31 | −$72.18M | -5.30% | -28.20% |
| Q4 FY2025Period end 2025-12-31 | −$68.55M | -4.80% | -27.79% |
| Q3 FY2025Period end 2025-09-30 | −$65.42M | -8.37% | -29.08% |
| Q2 FY2025Period end 2025-06-30 | −$60.37M | -7.21% | -24.01% |
| Q1 FY2025Period end 2025-03-31 | −$56.30M | -4.96% | -20.91% |
| Q4 FY2024Period end 2024-12-31 | −$53.64M | -5.85% | -20.27% |
| Q3 FY2024Period end 2024-09-30 | −$50.68M | -4.11% | -20.00% |
| Q2 FY2024Period end 2024-06-30 | −$48.68M | -4.53% | -21.87% |
| Q1 FY2024Period end 2024-03-31 | −$46.57M | -4.40% | -21.90% |
| Q4 FY2023Period end 2023-12-31 | −$44.60M | -5.62% | -21.65% |
| Q3 FY2023Period end 2023-09-30 | −$42.23M | -5.74% | -20.69% |
| Q2 FY2023Period end 2023-06-30 | −$39.94M | -4.56% | -32.81% |
| Q1 FY2023Period end 2023-03-31 | −$38.20M | -4.18% | -27.40% |
| Q4 FY2022Period end 2022-12-31 | −$36.67M | -4.79% | -28.60% |
| Q3 FY2022Period end 2022-09-30 | −$34.99M | -16.36% | -52.56% |
| Q2 FY2022Period end 2022-06-30 | −$30.07M | -0.29% | N/A |
| Q1 FY2022Period end 2022-03-31 | −$29.99M | -5.16% | N/A |
| Q4 FY2021Period end 2021-12-31 | −$28.51M | -24.31% | N/A |
| Q3 FY2021Period end 2021-09-30 | −$22.94M | N/A | N/A |
| Q1 FY2021Period end 2021-03-31 | $0 | N/A | N/A |
| Q4 FY2020Period end 2020-12-31 | −$22.19M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
